Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Depreciation & Amortization (CF) (2022 - 2023)

Historic Depreciation & Amortization (CF) for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $77000.0.

  • Lexeo Therapeutics' Depreciation & Amortization (CF) rose 3275.86% to $77000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $271000.0, marking a year-over-year change of. This contributed to the annual value of $304000.0 for FY2024, which is 1217.71% up from last year.
  • Lexeo Therapeutics' Depreciation & Amortization (CF) amounted to $77000.0 in Q4 2023, which was up 3275.86% from $78000.0 recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Depreciation & Amortization (CF) registered a high of $78000.0 during Q3 2023, and its lowest value of $57000.0 during Q1 2023.